Availability context

Check availability claims with price, dose and provider context

Availability can change by provider, dose and assessment route. Use shortage updates as context, then confirm live stock, current fee and suitability directly with a regulated provider.

Checks before you compare

  • Do not rely on old stock claims without checking the provider.
  • Dose strength, delivery timing and consultation route can affect availability.
  • Use cautious provider checks rather than urgency-led decisions.
📦 Supply Update

Is There a Mounjaro Shortage in the UK?

Latest update on supply constraints, why some pharmacies are temporarily out of stock, and where to find Mounjaro now

📅 Published:
🔄 Last Updated:

⚡ Key Takeaways

  • There is NOT a nationwide Mounjaro shortage in the UK—medication remains available through most channels
  • Some pharmacies have temporary stock constraints due to demand management, not manufacturing issues
  • Eli Lilly (manufacturer) confirms production is stable and increasing to meet UK demand
  • NHS rollout is creating allocation priority—commercial supply unaffected but distributed strategically
  • Multiple verified providers still have stock available—check current availability before panicking

What Happened

Recent social media posts and patient forums have reported difficulty obtaining Mounjaro from certain UK pharmacies, leading to concerns about a potential nationwide shortage. Here's what's actually happening:

  • Selected pharmacies have temporarily paused new Mounjaro prescriptions or limited supply to existing patients only
  • NHS pilot programmes are receiving priority allocation as tier 3 services begin prescribing (per NICE guidance from December 2025)
  • Demand management by Eli Lilly to ensure equitable distribution across NHS and private sectors
  • No manufacturing issues reported—production capacity actually increasing throughout 2025

📢 Eli Lilly UK Statement (December 2025):

"Mounjaro supply to the UK market remains robust. We are working closely with NHS England and private healthcare partners to ensure equitable access. Some pharmacies may experience temporary allocation adjustments as we prioritise NHS obesity treatment programmes, but overall supply is stable and growing."

Current Supply Status

✅ Good Availability
  • Major online pharmacies
  • Large private clinic networks
  • NHS tier 3 services (for eligible patients)
⚠️ Limited/Variable
  • Small independent pharmacies
  • High-street chains (Boots, Superdrug variable)
  • Some private GP practices
✅ Increasing Supply
  • All doses (2.5mg-15mg)
  • Starter kits readily available
  • Q1 2025 allocation higher than Q4 2024

What This Means for UK Patients

For NHS Patients

If you're awaiting NHS Mounjaro:

  • Supply is NOT the bottleneck—limited access is due to service capacity (limited tier 3 programmes), not medication shortage
  • Your waiting time relates to referral backlogs and eligibility assessment, not pharmacy stock
  • Once prescribed, dispensing should be straightforward through NHS pharmacy partners

For Private Patients (Existing)

If you're currently on Mounjaro privately:

  • Continue with your current provider—most are maintaining supply for existing patients
  • If your pharmacy says "out of stock," ask when next delivery expected (usually 7-14 days)
  • Alternative: Your prescriber can redirect prescription to another pharmacy if urgent
  • Don't panic-buy multiple months—worsens allocation for others and ties up your money

For New Private Patients

If you're trying to start Mounjaro privately:

  • Check multiple providers—stock varies significantly between clinics/online pharmacies
  • Online services generally have better access than small local pharmacies
  • Be patient—you may need to wait 1-2 weeks vs instant availability of mid-2024
  • Consider alternatives only if genuinely can't access Mounjaro (Wegovy has similar efficacy)

What You Should Do Next

✅ Recommended Steps

  1. Check current provider first: If already prescribed, contact your pharmacy—don't assume shortage
  2. Compare multiple sources: Use price comparison tools to check real-time availability
  3. Verify before switching: Don't change provider solely based on social media panic—confirm actual stock status
  4. Plan ahead: Order refills 1 week before running out (not day-of) to allow for any delays
  5. Ask about wait times: If ordering new, ask estimated dispatch timeline upfront

❌ What NOT to Do

  • Don't panic-buy 3-6 months supply—ties up allocation and isn't necessary
  • Don't pay inflated prices—if someone's charging £500/month citing "shortage," it's price-gouging
  • Don't turn to unverified sellers—fake products exploit shortage fears (see MHRA warning)
  • Don't stop treatment abruptly—if supply delayed, work with prescriber on interim plan

⚠️ Beware Shortage Scams

Scammers exploit shortage rumours to sell fake products. If anyone uses "limited supply" to pressure immediate purchase via social media, bank transfer, or suspiciously cheap prices—it's a scam. Legitimate shortages don't justify compromising on verification (see MHRA social media warning).

Why Is This Happening?

Several factors are creating perception of shortage despite stable supply:

1. NHS Rollout Allocation

NICE approval (Dec 2024) means Eli Lilly is reserving allocation for NHS tier 3 services. This is reallocation not shortage—total UK supply is higher, but split differently between NHS/private.

2. Massive Demand Growth

UK Mounjaro demand has tripled since mid-2024. Eli Lilly is scaling production but can't turn on supply overnight. Demand growth outpacing production increase = temporary constraints.

3. Global Competition

UK competes with US, EU, Australia for Mounjaro allocation. Eli Lilly prioritises based on regulatory approvals and contracts—UK is important market but not exclusive.

4. Strategic Pharmacy Management

Some pharmacies are limiting new patients to ensure existing patients' continuity. This looks like "shortage" but is actually patient prioritisation.

Outlook: Will This Improve?

Yes. Multiple positive indicators:

  • Eli Lilly's 2025 commitment: UK allocation increasing quarterly throughout 2025
  • New manufacturing capacity: Additional production facilities coming online Q2-Q3 2025
  • Competitor products: Wegovy supply also improving, reducing pressure on Mounjaro
  • NHS rollout stabilising: Initial surge will plateau as tier 3 capacity reached

Timeline: Most analysts expect supply/demand to balance by mid-2025 (June-August). Until then, expect variable availability but NOT complete unavailability.

🔍 Check Live Availability

See which verified UK providers currently have Mounjaro in stock with latest pricing

Compare Providers Now

⚠️ Disclaimer: This article provides information on Mounjaro supply status as of December 2025. Availability changes frequently. Always verify current stock with providers directly before making treatment decisions. This is not medical advice—consult your healthcare provider regarding medication options.